Since 1961, the enzyme L-asparaginase (L-ASNase) combined with danorubicin, vincristine and prednisolone is used in the treatment of ALL, with a survival rate of 80% in pediatric patients [3]. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.